Twelve patients with schizophrenia received positron emission tomography scans with 18F-deoxyglucose before and after 4 to 6 weeks of treatment with clozapine or thiothixene. Both stereotaxic and magnetic resonance image template methods were used to position regions of interest for metabolic rate analysis. Clozapine increased and thiothixene decreased metabolic rates in the basal ganglia; these effects were most marked on the right side. Within the basal ganglia, a superior to inferior gradient in drug effect was found for thiothixene but not clozapine. This gradient resembled in some respects observations on regional differences in D2 receptors in human autoradiography. Baseline metabolic rates also predicted clinical medication response, with right inferior caudate metabolic rates differentiating clozapine and thiothixene responders. Larger sample studies are needed to replicate and extend these initial findings.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Determining Ideal Management for Patients With Coexisting Prolactinomas and Psychiatric Symptoms: A Systematic Review.
J Psychiatr Pract
May 2024
Department of Obstetrics, Gynecology, and Women's Health-Repo Endocrinology, Division of Reproductive Endocrinology and Infertility, School of Medicine, Saint Louis University Saint Louis, MO.
Objective: Prolactinomas-pituitary tumors that overproduce prolactin-can cause various troublesome symptoms. Dopamine agonists (DAs) reduce prolactin production in the prolactin pathway, making them the first-line treatment for prolactinomas. However, the main side effect of DA treatment, hyperdopaminergia, is an explicit etiology for psychiatric side effects.
View Article and Find Full Text PDFWithdrawal syndrome after antipsychotics discontinuation: an analysis of the WHO database of spontaneous reports (Vigibase) between 2000 and 2022.
Psychopharmacology (Berl)
June 2024
Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine and Toulouse University Hospital (CHU), 37 Allées Jules-Guesde 31000, Toulouse, France.
Article Synopsis
- Withdrawal syndrome (WDS) may occur after stopping antipsychotic medications, potentially due to increased dopamine activity, especially with drugs closely binding to D2 receptors.* ! -
- Analysis of pharmacovigilance data revealed that insomnia, anxiety, and depression were common withdrawal symptoms, with tiotixene showing the highest risk of WDS among antipsychotics studied.* ! -
- The study found a weak correlation between the binding affinity of D2/5HT2A receptors and WDS risk, indicating that not all antipsychotics carry the same withdrawal risk, with some like chlorpromazine being safer.* !
Zuclopenthixol dihydrochloride for schizophrenia.
Cochrane Database Syst Rev
November 2017
Sheffield Health and Social Care, NHS Foundation Trust, Fulwood House, Old Fulwood Road, Sheffield, UK, S10 3TH.
Background: Oral zuclopenthixol dihydrochloride (Clopixol) is an anti-psychotic treatment for people with psychotic symptoms, especially those with schizophrenia. It is associated with neuroleptic malignant syndrome, a prolongation of the QTc interval, extra-pyramidal reactions, venous thromboembolism and may modify insulin and glucose responses.
Objectives: To determine the effects of zuclopenthixol dihydrochloride for treatment of schizophrenia.
Differences in Antipsychotic-Related Adverse Events in Adult, Pediatric, and Geriatric Populations.
Cureus
February 2017
Healthcare and Life Sciences, IBM T.J. Watson Research Center.
In recent years, antipsychotic medications have increasingly been used in pediatric and geriatric populations, despite the fact that many of these drugs were approved based on clinical trials in adult patients only. Preliminary studies have shown that the "off-label" use of these drugs in pediatric and geriatric populations may result in adverse events not found in adults. In this study, we utilized the large-scale U.
View Article and Find Full Text PDFAntipsychotic drugs and safety concerns for breast-feeding infants.
South Med J
November 2014
From the Rogosin Institute, New York, New York, the University of Louisville School of Medicine, Louisville, Kentucky, Georgia Regents University, Augusta, and the Veterans Affairs Outpatient Clinic, Spartanburg, South Carolina.
Antipsychotic drugs prescribed to treat psychiatric symptoms during the postpartum period are secreted into breast milk. Because breast-feeding is crucial to infant development, it is important to select a medication that poses the fewest adverse consequences. Aripiprazole, haloperidol, perphenazine, and trifluoperazine demonstrate no known developmental dangers.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!